Lista de obras - Je-Hwan Lee - Dominio Público Uruguay

A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma

artículo científico publicado en 2015

A case of de novo aleukemic mast cell leukemia without c-KIT mutations in exons 8 and 17.

artículo científico publicado en 2013

A case of refractory thrombocytopenia with 5q deletion: myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura

artículo científico publicado en 2014

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.

artículo científico publicado en 2011

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.

artículo científico publicado en 2017

Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study

artículo científico publicado en 2019

Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation.

artículo científico publicado en 2015

Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

scientific article published on 17 April 2020

Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System

artículo científico publicado en 2019

Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.

artículo científico publicado en 2018

Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5.

artículo científico

Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.

artículo científico publicado en 2017

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

scientific article published on 01 October 2019

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

artículo científico publicado en 2019

Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.

artículo científico publicado en 2016

Prognostic significance of theFLT3ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse ⬇️

artículo científico publicado el 21 de junio de 2011

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

artículo científico publicado en 2015

Significance of donor-derived isoagglutinins in ABO-Incompatible hematopoietic stem cell transplantation.

artículo científico publicado en 2008

The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients

artículo científico publicado en 2013

Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma

artículo científico publicado en 2019

Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment

artículo científico publicado en 2013

Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations

artículo científico publicado en 2013

Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)

artículo científico publicado en 2019

Lista de obras de Je-Hwan Lee

A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma

A case of de novo aleukemic mast cell leukemia without c-KIT mutations in exons 8 and 17.

A case of refractory thrombocytopenia with 5q deletion: myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura

A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.

Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study

Biomarkers for hepatic sinusoidal obstruction syndrome after hematopoietic cell transplantation.

Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL)

Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System

Comparison of anthracyclines used for induction chemotherapy in patients with FLT3-ITD-mutated acute myeloid leukemia.

Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5.

Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.

Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML

Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.

Prognostic significance of theFLT3ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse ⬇️

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

Significance of donor-derived isoagglutinins in ABO-Incompatible hematopoietic stem cell transplantation.

The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients

Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma

Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment

Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations

Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)